80 (look-see) "Tickers" Double 00 to $5. Charts

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Long Beach City College Announces Summer Learning Camps Long Beach City College (LBCC) is thrilled to introduce the Summer of Learning, a transformative series of free day camps that aim to empower local high school students and adult learners. Set to occur over eight weeks, this initiative includes engaging workshops in game design, skilled trades, and foundational...

Growth of the Portable Otoscope Market The global portable otoscope market is currently valued at approximately $300 million and is expected to skyrocket to around $550 million by the year 2034. This remarkable growth is indicative of a compound annual growth rate (CAGR) of 6.5% from 2025 to 2034. Factors driving this expansion include a rising demand for mobile...

Current State of Services PMI The Services PMI for August 2025 showed a growth rate of 52%, signaling that economic activity within the services sector continues to expand for the third consecutive month. The Business Activity Index recorded a robust 55%, demonstrating notable growth, and the New Orders Index also reflected strength at 56%, up from 50.3% in July....

Franklin Limited Duration Income Trust Announces Monthly Distribution Franklin Limited Duration Income Trust [NYSE American: FTF] recently revealed its monthly distribution plan to its shareholders. The Fund will provide a distribution of $0.0615 per share, enhancing the financial outlook for its investors. Details on the Distribution Plan The monthly distribution from...

Understanding the Class Action Investigation for Silvaco Group, Inc. As shareholder awareness grows, so does the importance of understanding potential securities class action investigations. This has come to light for Silvaco Group, Inc. (NASDAQ: SVCO), where concerns have arisen regarding possible misinformation disclosed by the company. Such developments often lead...